Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FWUXG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. on September 24, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. The delivery order is firm fixed price with an ultimate completion date of October 16, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has maintained federal registration since 2001 and holds a significant single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. This delivery order represents a specific task order issued under that larger indefinite delivery vehicle, which authorizes firm fixed-price orders for an extensive range of pharmaceutical products supporting military healthcare facilities. The company's core competency in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites positions it as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FWUXG?
SPE2DB25FWUXG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FWUXG worth?
The government has obligated $25,106 on SPE2DB25FWUXG.
Is contract SPE2DB25FWUXG an order under another contract?
Yes. SPE2DB25FWUXG is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUXG competed?
The extent of competition for SPE2DB25FWUXG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award